Table of Contents
Introduction
The Human and Animal Healthcare Industries
Human Drugs for Veterinary Use: Overview
Regulations for Human Drugs Applied in Veterinary Medicine
Regulation of Human Drugs for Veterinary Use in the US
Extra-Label Drug Use Algorithm
Regulation of Human Drugs for Veterinary Use in Canada
Regulation of Human Drugs for Veterinary Use in the EU
Unmet Needs and Factors Promoting Demand for Human Drugs in the Veterinary Space
Human Drugs Applied in Veterinary Medicine: Case Studies
Lysodren (Mitotane) in Dogs
Fluoxetine hydrochloride (Prozac) in Dogs and Cats
Benazepril (Lotensin, Fortekor) in Dogs and Cats
Quinidine Sulfate in Horses and Dogs
Chemotherapy in Dogs and Cats
Human Drugs for Veterinary Use: Key Marketed Products
Sildenafil
Methimazole
Amlodipine
Phenobarbital
Levothyroxine
Acetaminophen
Hydroxyzine
Humulin N
Pentoxifylline
Bethanechol
Human Prescription and OTC Drugs used in Dogs and Cats
Factors Driving the Crossover Drugs Market
Factors Restraining the Crossover Drugs Market
Key Established Global Players in the Crossover Drugs Market
Zoetis
Boehringer Ingelheim Vetmedica
Merck/MSD Animal Health
Elanco (Eli Lilly)
Merial (Sanofi)
Bayer Animal Health
Emerging Players in the Crossover Drugs Market
Cost-Efficient Business Model for Veterinary Pharmaceutical Companies
Business Models and Crossover Drugs: Examples and Future Focus Areas
Business Strategies Employed by Animal Health Companies with Crossover Drugs
Future Outlook in the Animal Health Market
Bibliography